PITTSBURGH, Oct 10, 2022 – RQM+, the leading MedTech service provider with the world’s largest global team of regulatory and quality experts, today announced the appointment of Ronnie Mahofski as head of mergers and acquisitions (M&A).
With more than 20 years of experience in the MedTech industry, Mahofski has held various positions at RQM+, including overseeing M&A integration and business development. He previously served as VP of engineering for Circadiance and as a project manager for MEDRAD. In his new role at RQM+, Mahofski is responsible for identifying and pursuing acquisition opportunities that complement its core regulatory services and provide a comprehensive range of fully integrated outsourced solutions to help get MedTech products to market faster and ensure ongoing regulatory compliance.
“We’re rapidly becoming the organization that will help medical device companies connect the dots from concept through market deployment and maintenance, expediting patient access to life-improving technologies,” said Mahofski. “In the coming years, we will continue to expand our offerings to support MedTech customers throughout the product lifecycle. They recognize the significant time and cost savings they can achieve by running many key processes in parallel through one trusted partner.”
Following RQM+’s recent acquisition of Jordi Labs, a provider of proprietary testing services for extractables and leachables, Mahofski is currently working with other potential acquisitions to help the company expand solutions that meet customer needs throughout the product development cycle.
Mahofski started his career as a nuclear submarine junior officer on the USS Tennessee. He earned his bachelor’s degree in systems engineering at the U.S. Naval Academy and his Master of Business Administration, with a concentration in finance, from Waynesburg University.
RQM+ is the leading MedTech service provider with the world’s largest global team of regulatory and quality experts. We provide comprehensive regulatory, quality, clinical and laboratory services, supporting market access throughout the entire product lifecycle for medical devices and diagnostics. With more former FDA, MHRA and notified body regulators than any other firm, the RQM+ team has deep expertise in all clinical specialties. RQM+ currently works for eight of the top 10 medical device manufacturers and seven of the top 10 IVD companies. For more information, visit RQMplus.com.